Phase I Study of Molecular-Guided Surgery for Pancreatic and Gastrointestinal Neuroendocrine Cancers
Summary
The purpose of this phase I study is to see if the use of 68Gallium- positron emission tomography and computer tomography (PET/CT) scans along with NETSPOT® (Advanced Accelerator Applications USA, Inc.) can better define the localization of Neuroendocrine tumors, enhancing the surgical removal of Neuroendocrine tumors (NETs).
General Information
NCT#: NCT03623984
Study ID: IRB-300001980
Trial Phase: Phase I
Trial Sponsor: University of Alabama
Therapies Used in This Trial: Surgery, Positron Emission Tomography - Computed Tomography (PET/CT), Gallium 68 (Ga-68) dotatate